Lyon Hospital, Hospices civils de Lyon
Welcome,         Profile    Billing    Logout  
 9 Trials 
12 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
NANCEY, Stéphane
USTAP, NCT04496063: USTekinumab in Fistulising Perianal Crohn's Disease

Active, not recruiting
4
33
Europe
Ustekinumab, Stelara, Placebo
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives, Janssen, LP
Crohn's Disease
06/25
12/25
EFFICACI, NCT03679546 / 2018-002673-21: : EFFicacy of Intravenous Infliximab Versus Vedolizumab After Failure of subCutaneous Anti-TNF in Patients With UlCerative Colitis

Active, not recruiting
4
150
Europe
Infliximab, Infliximab injection, Vedolizumab Injection, Vedolizumab
Rennes University Hospital
Ulcerative Colitis
12/24
05/25
VEDIAN, NCT06180382: Comparison of Vedolizumab Treatment to Adalimumab Dose Intensification in Crohn's Disease Patients With Loss of Response or Biomarker Activity to Adalimumab on First Line With Therapeutic Drug Concentration.

Recruiting
4
220
Europe
Adalimumab, Vedolizumab
Centre Hospitalier Universitaire de Saint Etienne, Takeda France
Crohn's Disease
01/26
01/27
NCT04183608 / 2018-003490-10: A Trial COmparing staNdard of Care Versus Treat to Target With telemonitoRing and Patient Education in Patients With Ulcerative cOlitis Initiating Adalimumab

Recruiting
4
238
Europe
Adalimumab, Calprotectin, e-Monitoring, Therapy Education
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives, AbbVie
Ulcerative Colitis
04/25
05/28
MAINTAIN-POP, NCT06925061: Target Engagement of EXL01 in the Prevention of Post-operative Recurrence of Crohn's Disease

Recruiting
2
80
Europe
After surgery for Crohn's disease, eligible patients will be randomized 1:1 to receive oral EXL01 or placebo with or without SoC treatment (based on investigator decision) for up to 24 weeks
Madeleine Bezault
Crohn Disease (CD)
09/26
12/26
PREDIRESPUC, NCT03724929 / 2018-001051-12: Value of Pharmacokinetic Assays in the Prediction of Therapeutic Response in Ulcerative Colitis

Terminated
N/A
67
Europe
Blood sample, Rectosigmoidoscopy
Centre Hospitalier Universitaire de Saint Etienne, Takeda, Theradiag
Ulcerative Colitis
04/22
06/22
RECOHFERRON, NCT04030676: QuantiFERON-CMV Test in a Prediction for Colic Cytomegalovirus Reactivation During Ulcerative Colitis

Recruiting
N/A
196
Europe
Biopsies, Blood samples
Centre Hospitalier Universitaire de Saint Etienne
Cytomegalovirus Infections
01/26
04/26
IPEC, NCT03915262: Exocrine Pancreatic Insufficiency's Prevalence in Active Crohn's Disease

Recruiting
N/A
50
Europe
Search for exocrine pancreatic insufficiency at week 0 and 12
Hospices Civils de Lyon
Crohn Disease
11/25
11/26
TRENCH 1, NCT05903066: TRansmural hEaliNg Definition in CroHn's Disease

Recruiting
N/A
210
Europe
Magnetic Resonance Enterography (MRE)
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
Crohn Disease
07/25
08/25
POP-REMIND, NCT03458195: Ileal Crohn's Disease and Post-operative Outcome: Prospective Cohort Study of the REMIND Group

Recruiting
N/A
575
Europe
bio-banking collection
Saint-Louis Hospital, Paris, France
Crohn Disease
12/25
12/26
Deeper, NCT04973423: STUDY OF THE ADDED VALUE OF A TRANSMURAL EVALUATION IN PATIENTS WITH CROHN'S DISEASE UNDER BIOTHERAPY WITH CLOSE FECAL CALPROTECTIN FOLLOW-UP

Recruiting
N/A
180
Europe
MRI
University Hospital, Clermont-Ferrand
Crohn Disease, Calprotectin, MRI
03/27
08/27
IMMUCARE-BASE, NCT03989323: A Clinical and Biological Prospective Database of Patients Treated With Anticancer Immunotherapy and Follow up of Their Immune-related Adverse Events irAE

Recruiting
N/A
2000
Europe
Estimation of the incidence of the irAE
Hospices Civils de Lyon
Cancer
07/29
07/29
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
NANCEY, Stéphane
USTAP, NCT04496063: USTekinumab in Fistulising Perianal Crohn's Disease

Active, not recruiting
4
33
Europe
Ustekinumab, Stelara, Placebo
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives, Janssen, LP
Crohn's Disease
06/25
12/25
EFFICACI, NCT03679546 / 2018-002673-21: : EFFicacy of Intravenous Infliximab Versus Vedolizumab After Failure of subCutaneous Anti-TNF in Patients With UlCerative Colitis

Active, not recruiting
4
150
Europe
Infliximab, Infliximab injection, Vedolizumab Injection, Vedolizumab
Rennes University Hospital
Ulcerative Colitis
12/24
05/25
VEDIAN, NCT06180382: Comparison of Vedolizumab Treatment to Adalimumab Dose Intensification in Crohn's Disease Patients With Loss of Response or Biomarker Activity to Adalimumab on First Line With Therapeutic Drug Concentration.

Recruiting
4
220
Europe
Adalimumab, Vedolizumab
Centre Hospitalier Universitaire de Saint Etienne, Takeda France
Crohn's Disease
01/26
01/27
NCT04183608 / 2018-003490-10: A Trial COmparing staNdard of Care Versus Treat to Target With telemonitoRing and Patient Education in Patients With Ulcerative cOlitis Initiating Adalimumab

Recruiting
4
238
Europe
Adalimumab, Calprotectin, e-Monitoring, Therapy Education
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives, AbbVie
Ulcerative Colitis
04/25
05/28
MAINTAIN-POP, NCT06925061: Target Engagement of EXL01 in the Prevention of Post-operative Recurrence of Crohn's Disease

Recruiting
2
80
Europe
After surgery for Crohn's disease, eligible patients will be randomized 1:1 to receive oral EXL01 or placebo with or without SoC treatment (based on investigator decision) for up to 24 weeks
Madeleine Bezault
Crohn Disease (CD)
09/26
12/26
PREDIRESPUC, NCT03724929 / 2018-001051-12: Value of Pharmacokinetic Assays in the Prediction of Therapeutic Response in Ulcerative Colitis

Terminated
N/A
67
Europe
Blood sample, Rectosigmoidoscopy
Centre Hospitalier Universitaire de Saint Etienne, Takeda, Theradiag
Ulcerative Colitis
04/22
06/22
RECOHFERRON, NCT04030676: QuantiFERON-CMV Test in a Prediction for Colic Cytomegalovirus Reactivation During Ulcerative Colitis

Recruiting
N/A
196
Europe
Biopsies, Blood samples
Centre Hospitalier Universitaire de Saint Etienne
Cytomegalovirus Infections
01/26
04/26
IPEC, NCT03915262: Exocrine Pancreatic Insufficiency's Prevalence in Active Crohn's Disease

Recruiting
N/A
50
Europe
Search for exocrine pancreatic insufficiency at week 0 and 12
Hospices Civils de Lyon
Crohn Disease
11/25
11/26
TRENCH 1, NCT05903066: TRansmural hEaliNg Definition in CroHn's Disease

Recruiting
N/A
210
Europe
Magnetic Resonance Enterography (MRE)
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
Crohn Disease
07/25
08/25
POP-REMIND, NCT03458195: Ileal Crohn's Disease and Post-operative Outcome: Prospective Cohort Study of the REMIND Group

Recruiting
N/A
575
Europe
bio-banking collection
Saint-Louis Hospital, Paris, France
Crohn Disease
12/25
12/26
Deeper, NCT04973423: STUDY OF THE ADDED VALUE OF A TRANSMURAL EVALUATION IN PATIENTS WITH CROHN'S DISEASE UNDER BIOTHERAPY WITH CLOSE FECAL CALPROTECTIN FOLLOW-UP

Recruiting
N/A
180
Europe
MRI
University Hospital, Clermont-Ferrand
Crohn Disease, Calprotectin, MRI
03/27
08/27
IMMUCARE-BASE, NCT03989323: A Clinical and Biological Prospective Database of Patients Treated With Anticancer Immunotherapy and Follow up of Their Immune-related Adverse Events irAE

Recruiting
N/A
2000
Europe
Estimation of the incidence of the irAE
Hospices Civils de Lyon
Cancer
07/29
07/29

Download Options